+Search query
-Structure paper
Title | Characterization of a dual BET/HDAC inhibitor for treatment of pancreatic ductal adenocarcinoma. |
---|---|
Journal, issue, pages | Int. J. Cancer, Vol. 147, Page 2847-2861, Year 2020 |
Publish date | Apr 17, 2020 (structure data deposition date) |
Authors | Zhang, X. / Zegar, T. / Weiser, T. / Hamdan, F.H. / Berger, B.T. / Lucas, R. / Balourdas, D.I. / Ladigan, S. / Cheung, P.F. / Liffers, S.T. ...Zhang, X. / Zegar, T. / Weiser, T. / Hamdan, F.H. / Berger, B.T. / Lucas, R. / Balourdas, D.I. / Ladigan, S. / Cheung, P.F. / Liffers, S.T. / Trajkovic-Arsic, M. / Scheffler, B. / Joerger, A.C. / Hahn, S.A. / Johnsen, S.A. / Knapp, S. / Siveke, J.T. |
External links | Int. J. Cancer / PubMed:32599645 |
Methods | X-ray diffraction |
Resolution | 1.05 - 1.25 Å |
Structure data | PDB-6yqn: PDB-6yqo: PDB-6yqp: |
Chemicals | ChemComp-EDO: ChemComp-P8T: ChemComp-HOH: ChemComp-P8Q: ChemComp-P8N: |
Source |
|
Keywords | GENE REGULATION / bromodomain / BRD4(BD1) / dual bromodomain HDAC inhibitor / structural genomics consortium / SGC |